Immunization Agenda 2030: mid-term review

Overview

The IA2030 Mid-Term Review provides a timely assessment of global immunization progress at the halfway point of the decade. Despite unprecedented challenges—including the COVID-19 pandemic, geopolitical instability, climate disruptions, and constrained financing—immunization efforts over the past five years have averted millions of deaths and introduced life-saving vaccines in many countries.

Yet, despite these efforts, most IA2030 targets remain off-track. The key indicators show persistent gaps in routine coverage, equity, and outbreak prevention across many countries.

Looking ahead, the Review reaffirms the enduring relevance of IA2030’s vision for: a world where everyone, everywhere, at every age fully benefits from vaccines for good health and well-being. In light of the shifting global context, it calls for renewed commitment to building sustainable country programmes, stronger integration with primary health care, and more focused prioritisation from global health agencies and partners – especially regarding fragile, conflict and vulnerable settings and middle-income countries. The Review sets out important recommendations to evolve governance, strengthen data-driven decision-making, and focus collective action on reaching zero-dose children, reducing outbreaks, and increasing coverage—while proactively preparing for the future of immunization beyond 2030.

A summary version of the Review will be presented to member states at the World Health Assembly in 2026.